Determining the significance of anti-K1 in hemolytic disease of the newborn (HDN)
By: P. Strohm, R. O’Shaughnessy, J. Moore, J. Blazina and M. Kennedy
Paid access
|Dec 2020Authors
P. Strohm
Southside Medical Center, Western Reserve Care System, Youngstown, United States
R. O’Shaughnessy
College of Medicine, The Ohio State University College of Medicine, Columbus, United States
J. Moore
College of Medicine, The Ohio State University, Columbus, United States
J. Blazina
College of Medicine, The Ohio State University, Columbus, United States
M. Kennedy
Transfusion Service, The Ohio State University Hospitals, Columbus, United States
DOI: https://doi.org/10.21307/immunohematology-2019-1009 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 40 - 42
Published on: Dec 14, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 P. Strohm, R. O’Shaughnessy, J. Moore, J. Blazina, M. Kennedy, published by American National Red Cross
This work is licensed under the Creative Commons License.